LONDON, June 15, 2023 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, has launched Dobutamine Injection, USP, in a 250mg/20mL vial in the US. With this ...
Hikma is introducing dobutamine injection, in a 250 mg/20 ml vial. With this launch, Hikma’s growing U.S. portfolio of sterile injectable medicines now exceeds 150 products spanning a wide range of ...
(UPDATED) A hastily convened collaboration between physicians, pharmacists, and industry experts has pulled together guidance for hospitals and clinicians navigating the US dobutamine shortage that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback